Introduction
Although the common femoral artery has been the traditional inflow source for distal bypass procedures, the use of more distal inflow sources has been increasing with recognition of the durability of these i5 types of bypasses.-The potential advantages of using a patent popliteal or tibial artery for inflow include decreased dissection and conservation of autogenous vein. The theoretical drawbacks of using a distal inflow Source include the presence of haemodynamically significant proximal occlusive disease (especially in the superficial femoral artery) and progression of occlusive disease in the postoperative period. This report documents our 12 year experience with popliteal or tibial based distal artery bypasses.
*Presented at the 8th annual meeting of the European Society for Vascular Surgery, Berlin, Germany (September 1994). Please address all correspondence to: Robert P. Leather, Vascular Surgery, A-61, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, U.S.A.
Of 2830 infrainguinal bypasses, a total of 106 popliteal or tibial to distal artery bypasses were performed in 95 patients during the review period (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) . Patients with a previous or simultaneous femoropopliteal bypass were excluded from this analysis, as were patients operated on for trauma. Chronic critical ischaemia was the indication for surgery in 92 cases (86.8%). Acute ischaemia or acute ischaemia overlying a history of chronic ischaemia was the indication for surgery in 13 cases (12.3%). One bypass was performed for claudication.
Patient demographics are listed in Table 1 . Of note is that the mean age of the patients was 59.6 years. Seventy-eight per cent were diabetic.
Patients were usually considered for this type of bypass if there was no evidence of significant disease in the proximal arterial system as evidenced by both noninvasive testing and arteriography. In these patients, the use of a distal inflow source was chosen Table 2 . The below-knee popliteal artery was used in the large majority of cases, whereas the anterior or posterior tibial arteries were used in 21 cases (19.8%).
Materials and Methods
The outflow arteries used are listed in Table 3 . The dorsalis pedis was used most frequently (36.7%). Almost all other outflow sites were within the distal third of the artery. In 35 cases (33%) pedal arches were absent. We did not measure peripheral resistance in these cases.
While only 11 bypasses (10.4%) in the entire group were performed in patients with a previous ipsilateral distal bypass, there were an additional eight bypasses performed in limbs lacking greater saphenous vein due to previous stripping or harvesting for coronary arterial bypass procedures.
In selecting the type of bypass, use of the ipsilateral greater saphenous vein (GSV) was preferred. If the below-knee portion of the GSV was large, it was prepared in situ with the modified Mills valvulotome. If the above-knee portion of the GSV was considerably larger, this segment was usually used. In patients lacking adequate GSV, the lesser saphenous vein was used in 17 cases, arm vein in four, and spliced vein segments in eight. Of the 60 procedures performed with excised vein, 26 (43.3%) were placed in an orthograde direction and the valves incised with the modified Mills valvulotome while the remaining 34 (56.7%) were placed in a reversed configuration. An orthograde configuration was selected whenever there was a subjectively large proximal-to-distal taper of the vein segment in question. The distribution of the types of conduits used is listed in Table 4 . Veins with external diameters of less than 3.0 mm were not used. In two patients primary amputations were done because of no run-off arteries. Follow-up of these bypasses was accomplished with physical examination, pulse volume recordings, segmental pressures, and Duplex ultrasonography within the first month postoperatively, every 3 months for the first year, and every 6 to 12 months thereafter.
Data was analysedand presented in life-table form according to the recommendations of the Ad Hoc Committee of the SoCiety of Vascular Surgery. 6
Results
There were three deaths (2.8%) within 30 days of the operation, all from myocardial infarction. Major postoperative complications included nonfatal myocardial infarction in four patients (3.8%), stroke in two (1.9%) and wound edge necrosis or infection in five (4.7%).
Eur J Vasc Endovasc Surg Vol 10, November 1995 Cumulative 5 year mortality was 53%, which was similar to that of all infrainguinal bypasses. Cumulative life-table primary graft patency was 90.7% at 1 year and 74.9% at 2 to 5 years as seen in Table 5 . Cumulative secondary graft patenc)~ as shown in Table 6 , was 93.8% at one year and 82.6% at 2 to 5 years postoperatively. Average follow-up was 17.6 months (range 1-108 months). Limb salvage is presented in Table 7 . There were five major amputations in this group, two from bypass occlusion and three with persistent nonhealing lesions in spite of a patent bypass. This latter group were comprised of one patient with diabetes and two patients with renal failure and diabetes.
There were 13 bypass occlusions in this series; 12 of these occlusions occurred in the excised vein group while there was only one occlusion in the in situ group. These 13 occlusions were caused by progression of inflow disease in six cases, all in the group of 22 patients with prior angiographic evidence of proximal disease. Nine limbs were rebypassed and salvaged; four of these were based from the femoral artery. Two patients with an occluded bypass required no further surgery.
There were two patients who required revision to a more distal outflow site. There was one bypass stenosis treated with a vein patch angioplasty. One stenosis in the donor artery was treated with transluminal angioplasty. One in situ bypass required ligation of a fistula. One bypass occluded, probably due to embolisation, and was successfully revised with catheter embolectomy.
The results were analysed in regards to several factors which might be thought to affect patency. These are presented in Table 8 . None of the other factors, such as diabetes, presence or absence of pedal arch, or gender had any effect on the outcome. The use of excised veins and the presence of inflow disease was associated with significantly lowered patency rates. Use of the dorsalis pedis artery as an outflow vessel was not associated with decreased bypass patency. Ankle brachial index (ABI) increased from pre-operative values of 0.31 + 0.11 to 0.86 + 0.20 (p < 0.05).
Discussion
Use of the popliteal and tibial arteries for inflow sources has been described in several reports, both as a part of a larger series 1'2 and smaller series dealing exclusively with these bypasses. 3-s'7-1~ The results presented in these series demonstrate that, in general, use of the popliteal and tibial arteries for inflow compares favourably with the use of the femoral artery.~,2,~2,13 Given the overall positive results in the aforementioned reports, what are the limitations of this type of operation? In the current series, 84 procedures were performed in patients with no angiographic evidence of more proximal occlusive disease; in this group there were only six bypass occlusions, none from progression of proximal disease. In particular, the 46 bypasses performed by the in situ technique, all of whom had no inflow disease, had only one occlusion in follow-up. Thus in cases in which an in situ technique is possible and in which an undiseased popliteal artery is available for inflow, there appears to be minimal risk of proximal disease progression, and is to be preferred to the more typical femorotibial bypass.
On the other hang there is the more difficult type of patient in whom there is some evidence of proximal occlusive disease. In this series, the haemodynamic adequacy of the popliteal or tibial artery was confirmed with intra-arterial pressure measurements. Patients with a gradient of 10 mmHg or greater were excluded from this study and were managed by either a proximal bypass or percutaneous transluminal angioplasty (PTA) of the proximal arter3~ as described by Wengerter et al. 3 The results with composite sequential bypass may be somewhat less than the 14 15 other options, ' whereas the results of a longer autogenous bypass are at least equivalent to the PTA/ distal bypass group. 1'2'12"13 Therefore these patients were excluded from this series.
There was a group of 22 patients in whom there was angiographic evidence of proximal occlusive disease but there was no measurable gradient at the completion of the bypass. These bypasses were usually performed in an effort to conserve vein or because there was insufficient vein to complete a longer bypass without splicing. There was evidence of proximal disease progression leading to bypass occlusion in six cases and an additional case of inflow stenosis treated with PTA. Thus, seven of 22 cases (31.8%) with a nonhaemodynamically significant proximal occlusive disease later developed significant proximal disease. It would seem that bypasses in this group perform less well and should at least be more closely monitored in the postoperative period as occlusion is more likely. However, in those cases in which there is so little available autogenous vein as to preclude any other option, use of a compromised inflow is acceptable.
The use of veins of less than 3.0 mm external diameter has been associated with decreased bypass patency; we avoided using such veins due to this data as well as that derived from a larger series of in situ bypasses. 3"16 Wengerter et al. 3 have also reported that use of the dorsalis pedis artery as an outflow vessel was associated with decreased bypass patency; this was not the case in this series. The differences in these results may either be due to the preferential use of the in situ technique or larger excised veins when available, but is impossible to directly confirm at this time.
In conclusion, the angiographically undiseased popliteal or tibial artery may be used for bypass inflow with expectations of excellent long-term patenc3~ especially when an in situ technique is possible. Use of a popliteal or tibial inflow below angiographically evident but haemodynamically undetectable occlusive disease may be associated with a higher rate of occlusion that is acceptable only if no longer autogenous bypass is possible.
